OClawVPS.com
Mass General Brigham
Edit

Mass General Brigham

https://www.massgeneralbrigham.org/
Last activity: 07.04.2026
Active
Categories: CareEdTechHealthTechInsurTechMedTechNetworksNonprofitResearchServiceSpecialty
Mass General Brigham is an integrated academic health care system, uniting great minds to solve the hardest problems in medicine for our communities and the world. Mass General Brigham connects a full continuum of care across a system of academic medical centers, community and specialty hospitals, a health insurance plan, physician networks, community health centers, home care, and long-term care services. Mass General Brigham is a nonprofit organization that is committed to patient care, research, teaching, and service to the community. In addition, Mass General Brigham is one of the nation’s leading biomedical research organizations and a principal teaching affiliate of Harvard Medical School.
Likes
6.67K
Followers
60.5K
Website visits
3.8M /mo.
Mentions
122
Location: United States, Massachusetts, Somerville
Employees: 10001+
Phone: +1 617-278-1000
Total raised: $50K
Founded date: 1994

Investors 1

DateNameWebsite
23.09.2021Shanda Gro...shanda.com

Funding Rounds 1

DateSeriesAmountInvestors
30.09.2022Grant$50K-

Mentions in press and media 122

DateTitleDescription
07.04.2026How MassMutual and Mass General Brigham turned AI pilot sprawl into production resultsEnterprise AI programs rarely fail because of bad ideas. More often, they get stuck in ungoverned pilot mode and never reach production. At a recent VentureBeat event, technology leaders from MassMutual and Mass General Brigham explained ho...
05.04.2026Digital Trends Doctors came up with an app to save you from jumping to wrong conclusionsWe have all been there. A delayed text reply suddenly means something is wrong. A neutral comment feels oddly critical. A small situation spirals into a full-blown worst-case scenario in seconds. That mental shortcut, where the brain jumps ...
01.04.2026JAMA Study: AI Scribes Deliver Modest EHR Time Savings Across 5 Major Health SystemsImage Credit: DC Studio What You Should Know The Scale of the Study: In the first major multi-site, multi-vendor study of its kind published in JAMA, researchers analyzed data from 8,581 ambulatory clinicians (including 1,809 AI scribe adop...
27.03.2026Navinci to attend NextGen Omics and Spatial Biology US as silver sponsor and pre-launch new multiplex kitNavinci to attend NextGen Omics and Spatial Biology US as silver sponsor and pre-launch new multiplex kit Fri, Mar 27, 2026 12:51 CET Report this content Uppsala, Sweden – March 27, 2026 – Navinci announced today its attendance at the Oxfor...
23.03.2026Oryon Cell Therapies: $42 Million Raised For Autologous Neuron Replacement Therapies Targeting Parkinson’s DiseaseOryon Cell Therapies, a clinical-stage biotechnology company developing autologous neuron replacement therapies for Parkinson’s disease and other neurodegenerative disorders, announced it has emerged from stealth with total funding of $42 m...
10.03.2026C-Further Unveils First Therapeutic Programmes Dedicated to Paediatric OncologyC-Further, an international consortium committed to creating new therapeutics for childhood cancers, today unveils the first early-stage therapeutic programmes for its pipeline, dedicated to paediatric oncology indications. Through its coll...
09.03.2026InterSystems Appoints Former NHS and Mass General Leader Dr. Tim Ferris as Vice President, Healthcare PracticeInterSystems, a creative data technology provider powering more than one billion health records globally, today announced the appointment of Tim Ferris, M.D., as Vice President, Healthcare Practice. The announcement comes as healthcare lead...
27.02.2026Neurizon Initiates Dosing of NUZ-001 in HEALEY ALS Platform TrialHighlights: First participant enrolled and dosed with NUZ-001 in Regimen I of the HEALEY ALS Platform Trial evaluating NUZ-001 for the treatment of ALS Approximately 160 participants with ALS will be enrolled in a 36-week randomised, double...
16.02.2026Кофеин в кофе и чае снижает риски развития деменцииПроанализировав данные более 131 000 человек, за которыми наблюдали более 40 лет, исследователи подтвердили, что ежедневное употребление кофе и чая однозначно защищает от развития болезни Альцгеймера и других форм когнитивных нарушений.Поче...
26.01.2026[Opinion] 2026: The Dawn of AI-Driven Drug Development(Yicai) Jan. 23 -- The next big leap for artificial intelligence in healthcare is no longer in the lab, but in clinical trials -- where drug development succeeds or fails. For years, the conversation around AI in healthcare has been dominat...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In